CliffBio
small molecule

LEUCOVORIN CALCIUM

LEUCOVORIN CALCIUM

Loss of exclusivity—loss of exclusivity
CompanyPar →See this company's full patent-cliff portfolio

Drug detail

Brand nameLEUCOVORIN CALCIUM
Active ingredientLEUCOVORIN CALCIUM
StrengthEQ 25MG BASE
Dosage formTABLET
RouteORAL
ModalitySmall molecule
FDA approvalOctober 1987
Marketing statusDISCN

More from Par

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.

LEUCOVORIN CALCIUM patent cliff — loss of exclusivity — | CliffBio